SEC Form D · Amendment · filed April 21, 2021
Code Biotherapeutics, Inc
Industry
Other Health Care
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Victor C. Stone · Hatfield, PADirectorKathy Rouan · Hatfield, PADirectorDmitry C. Kuzmin · Hatfield, PADirectorJoseph Truitt · Hatfield, PADirectorEdward C. Mathers · Hatfield, PADirectorRobert C. Getts · Hatfield, PAExecBrian Mcveigh · Hatfield, PAExec · DirectorRobert C. Lin · Hatfield, PADirectorLauren C. Kaskiel · Hatfield, PAExecRuss Fein · Hatfield, PADirectorLarissa Belova · ATLANTA, GADirectorDerek P. Watson · New York, NYDirectorJoseph Beach · Denver, COExec · DirectorFrank P. Savage · New York, NYDirectorShane Barratt · New York, NYExecMichael Abbott · New York, NYDirectorMichael Jordan · New York, NYDirectorSamuel G. Sawhook · Corpus Christi, TXExecRoshun Patel · New York, NYDirectorPaul Lucek · Rye Brook, NYDirectorCarole Spangler Vaughn · Spring, TXDirectorMartin Simonetti · Scottsdale, AZDirectorAnn Tanabe · Houston, TXDirectorAnthony Mallin · London, United KingdomExec · DirectorAdolfo F. Henriques · Hollywood, FLDirectorFrank J. Schwitter · Hollywood, FLDirectorMark H. Hildebrandt · Hollywood, FLExecJulie H. Neitzel · Hollywood, FLExecCarlos L. Macau, Jr · Hollywood, FLDirectorAlan H. Schriesheim · Hollywood, FLDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗